Scottish Radiological Society Spring Meeting 2021 May 14, 2021 09:00 AM - 05:00 PM — Virtual Meeting (online)
9th Annual Scottish Radiotherapy Research Forum Jun 03, 2021 12:30 PM - 05:00 PM — Virtual Meeting (online)
Medical Imaging Convention [rescheduled] Sep 15, 2021 - Sep 16, 2021 — National Exhibition Centre, Birmingham, England
Total Body PET 2021 conference [rescheduled] Sep 25, 2021 - Sep 27, 2021 — McEwan Hall, University of Edinburgh

eLearning

SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.


Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids

Author(s): I. Swift, A. Satti, V. Kim, B. J. Make, J. Newell, R. M. Steiner, C. Wilson, J. R. Murphy, E. K. Silverman, G. J. Criner

Abstract:
Long-term therapy with systemic corticosteroids is not recommended in the treatment of chronic obstructive pulmonary disease (COPD). However, experience demonstrates that some patients receive low dose therapy. Our objective was to describe the demographic, physiologic and radiologic characteristics of COPD patients treated with chronic systemic corticosteroids. We analyzed COPD subjects with GOLD I-IV disease in the COPDGene(R) study. Subjects were divided into 2 groups based on whether they reported using chronic oral steroids or not; 1264 subjects were included. Fifty-eight (4.5%) reported chronic systemic corticosteroid use. There were no differences in age, race, co-morbid conditions (other than asthma), or body mass index between the groups. There was a greater proportion of GOLD III (41% vs. 26%) and IV (41% vs. 13%) subjects in the group using chronic systemic corticosteroids. This group used more respiratory medications, required more oxygen (2.31 +/- 0.21 vs. 0.59 +/- 0.05 L/min; p < 0.0001), and walked less distance (245.4 +/- 17.4 vs. 367.2 +/- 3.9 meters; p < 0.0001). They reported more total (1.7 +/- 0.16 vs. 0.62 +/- 0.03; p < 0.0001) and severe exacerbations per year (0.41 +/- 0.05 vs. 0.18 +/- 0.01; p < 0.0001). BODE (5.0 +/- 0.3 vs. 2.6 +/- 0.1; p < 0.0001), MMRC (3.31 +/- 0.19 vs. 1.90 +/- 0.04; p < 0.0001) and SGRQ scores (54.9 +/- 2.9 vs 53.3 +/- 0.6; p < 0.0001) were higher. They also had a higher percentage of emphysema (22.4 +/- 1.9 vs. 14.0 +/- 0.4;%, p = <0.0001) on CT scan. COPD patients that report using chronic systemic corticosteroids have more severe clinical, physiologic, and radiographic disease.

Full version: Available here

Click the link to go to an external website with the full version of the paper


ISBN: 1541-2563 (Electronic) 1541-2563 (Linking)
Publication Year: 2012
Periodical: COPD
Periodical Number: 1
Volume: 9
Pages: 29-35
Author Address: Temple University, Philadelphia, Pennsylvania 19140, USA. iqpermut@gmail.com